Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.610
+0.050 (1.95%)
At close: Jan 16, 2026
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 972.78 million as of January 16, 2026. Its market cap has decreased by -11.00% in one year.
Market Cap
972.78M
Enterprise Value
1.51B
Revenue
627.22M
Ranking
n/a
PE Ratio
173.27
Stock Price
2.61
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 972.78M, an increase of 268.80%. That is a compound annual growth rate of 13.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 972.78M | 2.76% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.56B |
| Pro Medicus | 21.90B |
| Cochlear | 17.28B |
| Sonic Healthcare | 11.38B |
| Ramsay Health Care | 8.25B |
| Ansell | 4.82B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.52B |